Advertisement
Screener

EPOCRATES INC Research and Development Expense

EPOCRATES INC Research and Development Expense

EPOCRATES INC reported Research and Development Expense of $20.70 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-11.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2013-03-11

  • EPOCRATES INC research and development expense for the quarter ending 2012-12-31 was $5.20M, a 8.77% decline year-over-year.
  • EPOCRATES INC research and development expense for the quarter ending 2012-09-30 was $5.37M, a 1.07% increase year-over-year.
  • EPOCRATES INC research and development expense for the quarter ending 2012-06-30 was $5.36M, a 6.11% increase year-over-year.
  • EPOCRATES INC research and development expense for the quarter ending 2012-03-31 was $4.92M, a 1.97% decline year-over-year.
  • EPOCRATES INC research and development expense for fiscal 2012 was $20.70M, a 1.84% decline from fiscal 2011.
  • EPOCRATES INC research and development expense for fiscal 2011 was $21.09M, a 34.28% increase from fiscal 2010.
  • EPOCRATES INC research and development expense for fiscal 2010 was $15.70M, a 7.10% increase from fiscal 2009.
  • EPOCRATES INC research and development expense for fiscal 2009 was $14.66M.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2012-12-31$5.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11
$10.57M
derived: sum of 2 quarters · filed 2013-03-11
$15.93M
derived: sum of 3 quarters · filed 2013-03-11
$20.70M
10-K · filed 2013-03-11
2012-09-30$5.37M
10-Q · filed 2012-11-09
$10.73M
derived: sum of 2 quarters · filed 2012-11-09
$15.50M
10-Q · filed 2012-11-09
$21.36M
derived: sum of 4 quarters · filed 2013-03-11
2012-06-30$5.36M
10-Q · filed 2012-08-14
$10.13M
10-Q · filed 2012-08-14
$15.99M
derived: sum of 3 quarters · filed 2013-03-11
$21.30M
derived: sum of 4 quarters · filed 2013-03-11
2012-03-31$4.92M
10-Q · filed 2012-05-11
$10.62M
derived: sum of 2 quarters · filed 2013-03-11
$15.93M
derived: sum of 3 quarters · filed 2013-03-11
$20.99M
derived: sum of 4 quarters · filed 2013-03-11
2011-12-31$5.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11
$11.01M
derived: sum of 2 quarters · filed 2013-03-11
$16.07M
derived: sum of 3 quarters · filed 2013-03-11
$21.09M
10-K · filed 2013-03-11
$22.80M
10-K · filed 2012-03-19
2011-09-30$5.31M
10-Q · filed 2012-11-09
$5.52M
10-Q · filed 2011-11-10
$10.37M
derived: sum of 2 quarters · filed 2012-11-09
$15.39M
10-Q · filed 2012-11-09
$17.07M
10-Q · filed 2011-11-10
$16.58M
derived: sum of 4 quarters · filed 2013-03-11
2011-06-30$5.05M
10-Q · filed 2012-08-14
$5.21M
10-Q · filed 2011-08-12
$10.07M
10-Q · filed 2012-08-14
$11.56M
10-Q · filed 2011-08-12
$11.27M
derived: sum of 3 quarters · filed 2013-03-11
$16.39M
derived: sum of 4 quarters · filed 2013-03-11
2011-03-31$5.02M
10-Q · filed 2012-05-11
$6.21M
derived: sum of 2 quarters · filed 2013-03-11
$11.34M
derived: sum of 3 quarters · filed 2013-03-11
$16.20M
derived: sum of 4 quarters · filed 2013-03-11
2010-12-31$1.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11
$6.32M
derived: sum of 2 quarters · filed 2013-03-11
$11.19M
derived: sum of 3 quarters · filed 2013-03-11
$15.70M
10-K · filed 2013-03-11
$19.72M
10-K · filed 2012-03-19
2010-09-30$5.13M
10-Q · filed 2011-11-10
$9.99M
derived: sum of 2 quarters · filed 2011-11-10
$14.51M
10-Q · filed 2011-11-10
2010-06-30$4.87M
10-Q · filed 2011-08-12
$9.38M
10-Q · filed 2011-08-12
2009-12-31$14.66M
10-K · filed 2012-03-19